Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-163778
Filing Date
2025-07-24
Accepted
2025-07-24 06:17:42
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B5 d932470d424b5.htm 424B5 589499
2 EX-FILING FEES d932470dexfilingfees.htm   iXBRL EX-FILING FEES 15955
3 GRAPHIC g932470g04g04.jpg GRAPHIC 40442
4 GRAPHIC g932470g28d99.jpg GRAPHIC 34738
5 GRAPHIC g932470g89s08.jpg GRAPHIC 31417
  Complete submission text file 0001193125-25-163778.txt   876728

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT d932470dexfilingfees_htm.xml XML 6767
Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000
Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000 31 (0)71 203 6410
Pharvaris N.V. (Filer) CIK: 0001830487 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-278650 | Film No.: 251144435
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)